药物开发 药物开发
Mina Kmiecik1, Minhtrang Chu1, Annie Zhou1
1Stanford University, PALO ALTO, CA, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
这项研究调查了阿尔茨海默氏症 (AD) 的布梅塔尼德. 早期数据表明,布梅坦尼德可能会降低AD的患病率,这促使这项临床试验评估其在AD患者中的安全性和有效性.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 美国食品和药物管理局 (FDA) 批准的利尿剂Bumetanide正在被用于阿尔茨海默氏症 (AD) 的治疗.
- 临床前和电子健康记录 (EHR) 数据表明,布梅他尼德可能会降低AD的患病率.
- 随机对照试验是必要的,以确认bumetanide在AD的安全性和有效性.
研究的目的:
- 评估在生物标志物确认的阿尔茨海默病患者中布米坦胺的安全性和耐受性.
- 评估布梅他尼德在患有轻度认知障碍或因阿尔茨海默病而导致轻度痴呆症的人群中的临床和生物标志物影响.
主要方法:
- 第二阶段,随机,双盲,多臂,安慰剂控制,并行组研究.
- 参与者有生物标志物确认的AD,轻度认知障碍或由于AD引起的轻度痴呆症.
- 对安全性,耐受性,临床结果和生物标志物的评估.
主要成果:
- 为II期试验提出的研究方案和设计.
- 纳入标准集中在轻度认知障碍或轻度痴呆症由于AD.
- 排除标准涉及特定的健康状况和同时服用的药物.
结论:
- 介绍了阿尔茨海默病中布梅坦尼德II期临床试验的临床试验协议.
- 强调需要严格的临床评估布梅坦尼德在阿尔茨海默病的治疗潜力.
更多相关视频
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
3.3K
05:45Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
Published on: October 10, 2025
451
相关概念视频
Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation
279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
